---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-190746"
form_type: "8-K"
ticker: "FULC"
cik: "0001680581"
company_name: "Fulcrum Therapeutics, Inc."
filed_at: "2025-08-28T23:59:59+00:00"
generated_at: "2026-05-17T09:28:43.912196+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Fulcrum Therapeutics provides updated corporate presentation; no specific new facts disclosed in filing.

## Summary
- Company made an updated corporate presentation available on its website for investor meetings.
- Filing does not contain any new financial results, clinical data, or material operational changes.
- Presentation content not fully included in the submission; details are unknown from this filing alone.

## SEC filing metadata
- accession: 0001193125-25-190746
- form_type: 8-K
- ticker: FULC
- cik: 0001680581
- company_name: Fulcrum Therapeutics, Inc.
- filed_at: 2025-08-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680581/000119312525190746/0001193125-25-190746-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680581/000119312525190746/fulc-20250828.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-190746
- JSON: https://secwatch.observer/filing/0001193125-25-190746.json
- Plain text: https://secwatch.observer/filing/0001193125-25-190746.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.